Zongcai Liu

9 Jinsui Rd
Guangzhou, 510623, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Evaluation of efficacy and safety of AAV8-ΔC4ATP7B gene therapy in a mutant mouse model of Wilson's disease.

Evaluation of efficacy and safety of AAV8-ΔC4ATP7B gene therapy in a mutant mouse model of Wilson's disease.

Journal: Molecular therapy. Methods & clinical development

Published: September 16, 2024

Natural history and outcome of nonketotic hyperglycinemia in China.

Natural history and outcome of nonketotic hyperglycinemia in China.

Journal: Frontiers in neurology

Published: May 30, 2024

METTL14-Mediated Bim mRNA m6A Modification Augments Osimertinib Sensitivity in EGFR-Mutant NSCLC Cells.

METTL14-Mediated Bim mRNA m6A Modification Augments Osimertinib Sensitivity in EGFR-Mutant NSCLC Cells.

Journal: Molecular cancer research : MCR

Published: December 07, 2023

Circ-FOXO3 inhibits triple-negative breast cancer growth and metastasis via regulating WHSC1-H3K36me2-Zeb2 axis.

Circ-FOXO3 inhibits triple-negative breast cancer growth and metastasis via regulating WHSC1-H3K36me2-Zeb2 axis.

Journal: Cellular signalling

Published: November 28, 2023

Poliovirus receptor (PVR) mediates carboplatin-induced PD-L1 expression in non-small-cell lung cancer cells.

Poliovirus receptor (PVR) mediates carboplatin-induced PD-L1 expression in non-small-cell lung cancer cells.

Journal: Biochimica et biophysica acta. General subjects

Published: March 27, 2023

Assessment of the diagnostic value of serum ceruloplasmin for Wilson's disease in children.

Assessment of the diagnostic value of serum ceruloplasmin for Wilson's disease in children.

Journal: BMC gastroenterology

Published: July 11, 2021

The EGFR-P38 MAPK axis up-regulates PD-L1 through miR-675-5p and down-regulates HLA-ABC via hexokinase-2 in hepatocellular carcinoma cells.

The EGFR-P38 MAPK axis up-regulates PD-L1 through miR-675-5p and down-regulates HLA-ABC via hexokinase-2 in hepatocellular carcinoma cells.

Journal: Cancer communications (London, England)

Published: May 06, 2020

Enhanced histone H3 acetylation of the PD-L1 promoter via the COP1/c-Jun/HDAC3 axis is required for PD-L1 expression in drug-resistant cancer cells.

Enhanced histone H3 acetylation of the PD-L1 promoter via the COP1/c-Jun/HDAC3 axis is required for PD-L1 expression in drug-resistant cancer cells.

Journal: Journal of experimental & clinical cancer research : CR

Published: October 17, 2019

Distinct severity of phenotype in Hajdu-Cheney syndrome: a case report and literature review.

Distinct severity of phenotype in Hajdu-Cheney syndrome: a case report and literature review.

Journal: BMC musculoskeletal disorders

Published: October 08, 2019

Clinical features and mutational analysis in 114 young children with Wilson disease from South China.

Clinical features and mutational analysis in 114 young children with Wilson disease from South China.

Journal: American journal of medical genetics. Part A

Published: February 04, 2019

A novel GTPCH deficiency mouse model exhibiting tetrahydrobiopterin-related metabolic disturbance and infancy-onset motor impairments.

A novel GTPCH deficiency mouse model exhibiting tetrahydrobiopterin-related metabolic disturbance and infancy-onset motor impairments.

Journal: Metabolism: clinical and experimental

Published: December 07, 2018

Clinical features, BTD gene mutations, and their functional studies of eight symptomatic patients with biotinidase deficiency from Southern China.

Clinical features, BTD gene mutations, and their functional studies of eight symptomatic patients with biotinidase deficiency from Southern China.

Journal: American journal of medical genetics. Part A

Published: November 08, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026